CanSino Biologics, Inc. Class H (HK:6185) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
CanSino Biologics Inc. has announced the composition of its board of directors, which includes Dr. Xuefeng YU as Chairman and Executive Director, alongside other executive, non-executive, and independent directors. The company also disclosed the structure of its three Board committees—Audit, Remuneration and Assessment, and Nomination—with details on each member’s committee roles.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
